Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vortioxetine for Depression After Radiotherapy in Head and Neck Cancer
NCT04818099Phase 3Unknown
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Oct 2020
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vortioxetine in major depressive disorder (MDD), cognitive dysfunction, sponsored by Sun Yat-sen Memorial Hospital. Status: unknown.
02
Drugs
vortioxetine
03
Conditions
major depressive disorder (MDD)cognitive dysfunction
Beyond the preview
Go deeper on NCT04818099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04818099.